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LRYGB had the greatest lifetime costs at every age ($13,506 vs. no treatment, $3,859
vs. LAGB), but also the greatest amount of QALYs gained (2.54 more vs. no treat-
ment, 1.32 vs. LAGB), leading to a lower ICER than LAGB when compared with no
treatment ($5,324 and $7943/QALY, respectively). When LRYGB was compared to
LAGB, a relatively low ICER of $2,918/QALY resulted at age 40. ICERs in both compari-
sons increased steadilywith age. In one-way sensitivity analyses for LRYGBagainst no
treatment, the most sensitive parameters were medical costs associated with initial
baseline BMI (ICER varied 187%), and medical costs associated with LRYGB efficacy
(80%). The results of LAGB against no treatment were similar, although utility asso-
ciated with efficacy was much more sensitive in comparison. In results for LRYGB
versus LAGB, the model was most sensitive to recurring medical cost parameters
associated with efficacy of treatment. CONCLUSIONS: Both LRYGB and LAGB were
found to be cost-effective compared to no treatment for morbidly obese people,
with ICERs below $25,000 up to age sixty. These results were robust to reasonable
model parameter changes. This study also suggests that LRYGBmay bemore cost-
effective than LAGB due to the relative improvement in QALYs gained.
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CLINICAL AND COST EFFECTIVENESS OF BARIATRIC SURGERY FOR OBESE
PATIENTS: ECONOMIC EVALUATION IN SOUTH KOREA
Song HJ, Lee HJ, Lee JY, Choi JE, Oh SH, Kwon JW
National Evidence-based Healthcare Collaborating Agency (NECA), Seoul, South Korea
OBJECTIVES: To evaluate the cost-effectiveness of bariatric surgery in obese Ko-
rean people. METHODS: The target population was obesity patients defined as
having a body mass index (BMI) of BMI30kg/m2 with diabetes. This study per-
formed in Healthcare system perspectives. The bariatric surgery comprised lapa-
roscopic adjustable gastric banding (LAGB), Roux-en Y gastric bypass (RYGB), and
Sleeve gastrectomy (SG). The comparison, non-surgical treatments consisted of
physician visit, exercise, diet, and pharmacotherapy. For cost-effectiveness anal-
ysis, the decision model with a one year time horizon was used. The effectiveness
associated with percent weight change from baseline, BMI reduction, and propor-
tion of patients with more than 10% weight change. The cost data was collected
from the survey of 9 medical centers who had conducted these obesity treatments
and Korean national health insurance statistics, based on 2011 costs. The effective-
ness data and distribution of surgery and complication was collected from 7multi-
center, 485 patients retrospective chart review. Incremental cost-effectiveness ra-
tio (ICER) of bariatric surgery compared to non-surgery interventions was
calculated in obese people. Subgroup analysis using various BMI levelwith/without
diabetes and probability sensitivity analysis were conducted to assess the stability
of base-case results. RESULTS: The bariatric surgery had higher cost (US$9273) and
better effectiveness(18.1% weight loss), the Incremental cost-effectiveness ratio
(ICER) was US$512 per one-percent weight loss. Through the subgroup and sensi-
tivity analysis under various conditions, robustness of the study results was also
demonstrated. CONCLUSIONS: The cost-effectiveness study for clinical outcomes
indicated that bariatric surgery was clinical and cost effective alternative to con-
ventional therapy in obese patients.
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COST-UTILITY ANALYSIS OF BARIATRIC SURGERY FOR THE TREATMENT OF
OBESE PATIENTS IN SOUTH KOREA
Kwon JW, Song HJ, Lee HJ, Lee JY, Choi JE, Oh SH
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OBJECTIVES: The purpose of this study was to assess the cost-utility of bariatric
surgery compared to non-surgical interventions in obese Korean people.
METHODS: We used Markov model comparing the lifetime expected costs and
quality adjusted life years (QALY) between bariatric surgery and non-surgery in-
tervention from Korean Healthcare system perspectives. Our target cohort con-
sisted of obese people defined as having a body mass index (BMI) of 30-40 in South
Korea. The starting age of cohort was 30 years old. The non-surgical interventions
include physician visit, exercise, diet, and pharmacotherapy. The cycle length was
1 year and used half-cycle correction. The health status comprised five states such
as no comorbidity, mild/moderate comorbidity (diabetes or/and hypertension or/
and, dyslipidemia), severe comorbidity (CHD or/and stroke), death due to CVD, and
death due to other cause. Input data of transition probability for eachdisease status
and utility weight calculated from the relationship between weight loss and QALY
gain using Korean National Health and Nutrition Examination Survey data. The
rate of death due to CVD and other cause were calculated Korean death statistics.
The cost datawas collected from the survey of 9medical centerwhohad conducted
those obesity treatments and Korean national health insurance statistics, based on
2011 costs. Discount of 5% was applied in cost and QALY. Incremental cost-effec-
tiveness ratio (ICER) of bariatric surgery compared to non-surgery interventions
was calculated. RESULTS: The cost-utility study indicated that bariatric surgery
had US$1,522 Incremental costs and 0.86 Incremental QALY compared non-surgi-
cal interventions. Through the base case analysis, ICER was US$1771/QALY. The
sensitivity analyses under a variety of assumption, robustness of the study results
were also demonstrated. CONCLUSIONS: The study indicated that bariatric sur-
gery was cost-effective alternative to non-surgical interventions over lifetime, pro-
viding substantial lifetime benefits in obese Korean people.
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CLINICAL AND ECONOMIC CHARACTERISTICS OF PATIENTS RECEIVING TOTAL
HIP REPLACEMENT SURGERY WITH AND WITHOUT MUSCLE
ATROPHY/WEAKNESS
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OBJECTIVES: To assess differences in demographics, comorbidities, and healthcare
costs and utilization among patients undergoing total hip replacement (THR) surgery
with and without muscle atrophy/weakness (MAW).METHODS: Using large US ad-
ministrative claims databases, we examined individuals aged 50 with commer-
cial insurance or Medicare supplemental insurance whowere hospitalized for THR
between January 2006 to September 30, 2009. The first hospitalization was defined
as the index stay. Three cohorts were further identified based on whether individ-
uals had medical claims associated with MAW over the 12 months pre-index stay
(pre-MAW), patients whose first MAW claim occurred during or within the 12
months after the index stay (post-MAW), or patients without any MAW claim (no-
MAW). Demographics and comorbidities during 1 year prior to the index stay, and
health care utilization and costs during 1 year before and after the index stay were
compared among groups. Multivariate regressions were performed to estimate
1-year post-indexmedical costs controlling for cross-cohort differences. RESULTS:
There were 23,127 commercially-insured (pre-MAW: 323; post-MAW: 1,176; no-MAW:
21,628) and19,607Medicare (pre-MAW:332;post-MAW:909;no-MAW:18,366)patients
identified. Compared with commercially-insured patients in the post-MAW and no-
MAW cohorts, individuals in the pre-MAW cohort were more likely to have any hos-
pitalization during the 12 months pre-index stay (33.4% vs. 12.7% vs. 10.5%; both
p0.05), ahigherCharlsoncomorbidity indexscore (5.5vs. 4.3vs. 3.9; bothp0.05), and
higher total costs ($35,022 vs. $15,011 vs. 12,952; both p0.05). Controlling for cross-
cohort differences, both pre-MAW and post-MAW cohorts had significantly higher
totalhealthcare costs ($6697and$8593) than theno-MAWcohort (bothp0.01) during
the 12 months post-index stay. Similar trends were observed in the Medicare
population. CONCLUSIONS: Among US patients receiving THR surgery, those with
MAW had higher health care costs than patients without MAW.
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VARIABLES ASSOCIATED WITH LENGTH OF STAY AND ICU NEED IN ROUX-EN-
Y GASTRIC BYPASS SURGERY FOR MORBID OBESE PATIENTS: A CROSS-
SECTIONAL STUDY BASED ON THE PUBLIC HEALTH SYSTEM DATABASE
(DATASUS) IN BRAZIL
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OBJECTIVES: This is an exploratory analysis of potential variables associated with
roux-en-Y gastric bypass (RYGB) surgery hospitalization resource use pattern.
METHODS: Cross-sectional study based on a public database (DATASUS) records.
Inclusion criteria were patients undergoing RYGB between January 2008 and June
2011. Dependent variableswere length of stay and ICUneed. Independent variables
were: gender, age at surgery (continuous or categorized as older/younger than 60),
hospital volume (high volume: 100 RYGB/year; low volume: 100 RYGB/year),
surgery at certified center of excellence (CoE) by the American Society forMetabolic
and Bariatric Surgery (ASMBS) (yes/no), year of hospitalization. Univariate and
multivariate analysis (logistic regression for ICU need and linear regression for
length of stay) were performed. RESULTS: Data from 13,069 surgeries were ana-
lyzed. 14.8% of patients were male, mean age 38.210.4 years, 52.2% undergone
surgery in a high volume hospital, 11.6% from a certified CoE by ASMBS. In the
univariate analysis of potential factors associated with outcomes of interest, the
variable with highest effect size for length of stay was hospital volume (high vol-
ume 3.81.8 days vs 6.37.6 low volume, p0.001), whereas for ICU need it was
certified CoE (50.0% vs. 1.3%, p0.001). Final model for ICU need after logistic re-
gression includes certified CoE (OR 0.009, CI95% 0.006-0.014), hospital volume (OR
3.16, CI95% 2.93-3.41) and age group (OR 1.93, CI95% 1.46-2.57). Themost important
variable in the final model for log-transformed length of stay is hospital volume
(adjusted coefficient -0.338, CI95% -0.379 to -0.297); association was also found for
certified CoE, gender and age. In high volume hospitals, variance of RYGB length of
stay is significantly lower than variance in low volume hospitals (SD 2.1 vs. 11.0,
p0.001). CONCLUSIONS: High volume hospitals are strongly associated with
shorter length of stay and less variability, and ASMBS certification is strongly as-
sociated with less need for ICU.
SURGERY – Patient-Reported Outcomes & Patient Preference Studies
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THE IMPORTANCE OF MEDICAL APPOINTMENTS AFTER ROUX-EN-Y GASTRIC
BYPASS IN MORBID OBESE PATIENTS: ASSOCIATION BETWEEN ADHERENCE TO
MEDICAL FOLLOW-UP VISITS AND THE BARIATRIC ANALYSIS AND REPORTING
OUTCOME SYSTEM (BAROS) SCORE BASED ON AN ADMINISTRATIVE
DATABASE (DATASUS) IN BRAZIL
Asano E1, Rasera junior I2, Shiraga EC2, Cunha PG1
1Johnson & Johnson Medical Brasil, Sao Paulo, Sao Paulo, Brazil, 2Gastroenterology and Obesity
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OBJECTIVES: Correct clinicalmanagement ofmorbid obese patients does not begin
and neither ends with bariatric surgery. The aim of this study was to evaluate the
association between number of medical follow-up visits after surgery and patient
outcomes in morbid obese patients undergoing roux-en-Y gastric bypass (RYGB).
METHODS: This is a database (DATASUS) retrospective cohort study. Inclusion
criteria was patients undergoing RYGB between January 2008 and June 2010with at
least one medical follow-up visit. The dependent variable was the Bariatric Anal-
ysis and Reporting Outcome System (BAROS) score, which combines clinical (%Ex-
cess weight loss, co-morbidity resolution) and quality of life outcomes in one cat-
egorical variable (failure/fair/good/very good/excellent). Independent variable was
adherence tomedical follow-up visits, adjusted for potential covariates. Univariate
and multivariate analysis (by linear regression) were performed at 12 and 24
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months after surgery. RESULTS: A total of 5311 patients were part of the study
cohort (85.1% female, age at surgery 38.5  10.1 years, 61.9% with at least one
obesity-related co-morbidity). At 12-months, data from 1,035 patients were avail-
able, with 96.1% of patients scoring good or better at BAROS. Adherence to fol-
low-up visits was not significantly associated with BAROS at 1 year (coefficient
-0.046, 95%CI -0.218 to 0.126). At 24-months, data from 319 patients were available,
with 92.2% scoring good or better at BAROS. Adherence to follow-up visits was
significantly associated with a better BAROS score (coefficient 1.66, 95%CI 1.13-
2.18). Inmultivariate linear regression, presence of co-morbidity is associated with
higher BAROS scores at 24months (p0.001), and adherence to follow-up visits acts
as an effectmodifier of this association, with a positive effect in the sub-groupwith
co-morbidity. CONCLUSIONS: Patients with obesity related co-morbidity seems to
benefitmore fromRYGB at 24months post-surgery. Adherence tomedical appoint-
ments is an important variable to drive better outcomes in this population.
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A SYSTEMATIC REVIEW OF THE USE OF PATIENT-CENTERED OUTCOME
MEASURES IN STUDIES OF SPINAL FUSION SURGERY FOR DEGENERATIVE DISC
DISEASE: IMPLICATIONS FOR COMPARATIVE EFFECTIVENESS RESEARCH
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OBJECTIVES: While radiographic fusion and pain are commonly-reported out-
comes in clinical studies of spinal fusion for degenerative disc disease (DDD), pa-
tient functioning is often the main goal of treatment. Given the increasing empha-
sis on patient-centered outcomes in comparative effectiveness research, we
sought to examine the frequency and trends in reporting of functional outcomes in
spinal fusion studies.METHODS:A search of PubMed and Cochrane from July 2011,
1975was conducted. Inclusion criteria included: English, abstract available, human
subjects, 1 arm with lumbar fusion, pain/functional outcomes reported, mini-
mum two years follow-up, adults with DDD including: spondylosis, spondylolis-
thesis, stenosis, disc herniation, degenerative scoliosis, standalone DDD, or disco-
genic back pain, all with mention of degeneration. Functional outcomes included
the Oswestry Disability Index (ODI), SF36 Physical Component (PCS), and SF36
Physical Functioning (PF) Subscale. Results were stratified by study type (random-
ized control trial [RCT] vs. non-RCT) and publication year (2007-2011 versus before
2007). RESULTS: Out of 1526 titles and abstracts reviewed, 64 studies met study
inclusion criteria with a median sample size of 51 and median age of 55. Thirty-
seven (58%) of these were published between 2007 and 2011, with only 16 (25%)
being RCTs. ODI was the most commonly reported patient centered outcome
(N48, 75% of studies), while SF36 scores were less commonly reported (n11, 17%
of studies). A higher proportion of RCTs reported functional outcomes compared to
non-RCTs (ODI: 81% versus 73%; PCS or PF: 25% versus 15%). Thirteen studies (81%)
from 2007-2011 reported ODI compared to 67% (N18) of older studies.
CONCLUSIONS: In published studies of spinal fusion surgery for DDD, we found an
increasing use of functional outcomesmeasures, especially in randomized clinical
trials, over the past five years. The reporting of suchmeasures will greatly enhance
opportunities to conduct meta-analyses of clinical trial results to inform decisions
about comparative effectiveness.
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THE IMPROVEMENT OF QUALITY OF LIFE IN PATIENTS TREATED WITH
BARIATRIC SURGERY
Oh SH, Song HJ, Lee HJ, Lee JY, Choi JE, Kwon JW
National Evidence-based Healthcare Collaborating Agency (NECA), Seoul, South Korea
OBJECTIVES:This studywas conducted to compare the improvement of quality of life
in patients treated with either bariatric surgery or conventional therapy in obese Ko-
rean people.METHODS: The quality of life was investigated for 53 patients who un-
derwentbariatric surgeryand25patientswhowere treatedbyconventional therapy in
7 tertiarymedical centers. Thequality of lifewasmeasured right before treatment and
after at least fivemonth of that by self-report instruments; The instruments for mea-
suring quality of lifewere EuroQol-5D (EQ-5D), Impact ofWeight onQuality of Life-Lite
Questionnaire (IWQOL-Lite), and Obesity-related Problem scale (OP-scale). Through
themedical chart review, percent weight change from baselinewas investigated. The
differenceofQOL improvement frombaselinebetween two treatmentswascompared
using the t-test. The relationship betweenweight control and QOL improvement was
also investigated. RESULTS: The improvement of QOL was 0.174 in EQ-5D index
score and 24.6 in VAS score for bariatric surgery, and 0.071 and 17.8 for conven-
tional therapy. QOL score using IWQOL-Lite and OP-scale were 33.4 and 39.3 for
bariatric surgery and 14.3 and 9.6 for conventional therapy. Measuring by obesity-
specific questionnaires (IWQOL-Lite and OP-scale), the improvement of QOL before
and after treatments was significantly higher in bariatric surgery than conven-
tional therapy, but the general questionnaires (EQ-5D 3 level and EQ-VAS) did not
show. The percent weight change from baseline had positive correlation with the
improvement of QOL. CONCLUSIONS: The improvement in quality of life was sig-
nificantly higher among bariatric surgery group compared with the conventional
therapy group, especially for the obesity specific questionnaires.
SURGERY – Health Care Use & Policy Studies
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ASYMPTOMATIC CHOLELITHIASIS IN KIDNEY TRANSPLANT RECIPIENTS:
SYSTEMATIC REVIEW OF SURGERY APPROPRIATENESS
Mata A1, Bouza C2, Salinas J1, Salvatierra LD1, Freire E1
1La Paz University Hospital, Madrid, Spain, 2Instituto de Salud Carlos III, Madrid, Spain
OBJECTIVES: Cholecystectomy is one of the most common surgical interventions
performed around the world, and it consumes great healthcare resources. Though
usually effective and safe, it associates adverse events, sometimes severe, being
considered a quality indicator of the healthcare system performance. Asymptom-
atic gallstones are not considered an indication for surgery. Immunosupression
among other conditions is an exception to this rule. Clinical controversy exists in
renal transplant recipients where cholelithiasis incidence is recognized to be high
and complications of gallstones may be harmful. Our objective is to assess the
appropiate use of cholecystectomy in kidney transplant recipients with asymp-
tomatic cholelithiasis. METHODS: We performed a systematic review of the pub-
lished literature since 1997 to date, using Medline, Embase, ISI Web of Science and
Sumsearch. The search strategy included the terms: asymptomatic gallstones,
cholelithiasis, cholecystectomy, and kidney or renal transplant. Studies were se-
lected for inclusion on the basis of their population, intervention, and clinically
relevant outcomes. Studies were critically appraised with respect to methodolog-
ical quality, grade of scientific evidence, and clinically relevant outcomes.
RESULTS: From 38 potentially relevant studies, 19 articles were disregarded be-
cause of pre-transplant and other conditions. Nineteen studies were included.
Much of the research identified was of poor quality. As there was considerable
heterogeneity we considered it inappropriate to pool the data for meta-analysis.
There is little information on its optimal approach, appropriate indications, limit-
ing factors, side effects, long-term outcomes and potential advantages over
surveillance. CONCLUSIONS: Current available literature shows a low degree of
consensus regarding cholecystectomy indication in asymptomatic patients. Some
studies advocate surgery to avoid gallstones complications while others claim that
risks are the same as in general population. Uncertainty remains surrounding this
problem and research of goodmethodological quality is urgently required to define
the appropriate role of surgery.
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RELATIONSHIP BETWEEN PATIENT CHARACTERISTICS AND DISCHARGE
DESTINATION FOLLOWING TOTAL KNEE ARTHROPLASTY (TKA)
Kirkness CS1, Peters CL2, Fritz JM2
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OBJECTIVES: Recent reductions in length of hospital stay after TKA have resulted in
an increased demand on extended care facilities (ECF) to manage TKA postoperative
care. An exponential increase inTKAprocedures is expected by 2030 anda shortage of
resources to meet the increase is projected. Determining what factors affect patients
to be discharged directly home or to rehabilitation may assist resource allocation
decisions. The objective of this studywas to identify if preoperative patient character-
istics (age, gender, comorbidities, physical function and activity) were associatedwith
discharge to an ECF versus discharge directly home after an elective TKA.METHODS:
Patients40 years old with a primary unilateral TKA, excluding those with a 2nd TKA
surgery within the year, were retrospectively extracted from a clinical orthopedic
database between Septeber 1, 2008 – November 30, 2010. Discharge location and pre-
operative comorbidities (diabetes, hypertension, obesity [bmi30 kg/m2], cancer, os-
teoporosis, chronicbackpain, insomnia, osteoporosis)wereobtainedbychart abstrac-
tion from the electronicmedical record. Using logistic regression analysis, odds ratios
were adjusted for age, gender, preoperative patient education, levels of preoperative
physical health and activity and insurance type (medicaid, medicare, private).
RESULTS: A total of 174 patients with average age 63.8 years (SD 10.2, 41-85) were
included in the study. Overall, one-third of patients (35.6%, 62) of patients were
discharged to a ECF. In adjusted ORs, the likelihood of going to a ECF postopera-
tively were 3.23 times (95% confidence interval[CI]1.27-8.16) more likely for those
age 65 years compared to those 65 years; 2.86 times (95% CI 1.11-7.37) in
patients with a diabetes and 2.99 (95% CI 1.15-7.80) times for those with a cancer
diagnosis compared to those without diabetes and cancer, respectively.
CONCLUSIONS: We identified specific patient variables that may predict postop-
erative discharge destination. Identification is paramount to avoid delays in pa-
tient discharge and to efficiently manage available resources.
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RATES AND COSTS OF HOSPITALIZATION IN OBESE PATIENTS WITH
BARIATRIC SURGERY
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OBJECTIVES: The goal of this study was to compare the health care resource utili-
zation and costs between obese patients who received laparoscopic adjustable
gastric banding (LAGB), laparoscopic Roux-en-Y gastric bypass (lRYGB), open Roux-
en-Y gastric bypass (oRYGB), and sleeve gastrectomy (SG).METHODS:Marketscan
claims data (2005 to 2010) were analyzed for patients 18 years old, who received
LAGB, lRYGB, oRYGB, or SG (identified using ICD-9-CM and CPT codes) and re-
mained continuously insured for12months following first date of surgery (index
date). Patients with ambiguous bariatric procedure coding or stomach or intestinal
cancer codes were excluded. RESULTS: A total of 52,359 claims met inclusion cri-
teria: LAGB (n21,075), lRYGB (n26,206), oRYGB (n4,497), and SG (n581), aver-
aging 44 to 46 years old and about 80% female. 35.5% LAGB had type II diabetes
codes compared to lRYGB (40.6%), oRYGB (42.3%), and SG (40.8%). 10.0% of the LAGB
patients were hospitalized within 12 months post-index date compared to lRYGB
(17.4%), oRYGB (20.5%), and SG (13.8%). LOS were 4.9, 6.0, 9.3, and 10.0 days; total
costs were $21,242 vs. $22,988; $31,603; and $35,631; respectively. In the diabetic
subgroup, 12.1% LAGB, 19.2% lRYGB, 23.9% oRYGB, and 17.3% SG were hospitalized
within 12 months. LOS were 5.4, 6.4, 10.4, and 11.3 days; total costs were $22,840;
$24,816; $37,698; and $35,128; respectively. Similarly, out of those with 36-month
follow-up data, 29.0% (1162/4012) LAGB patients were hospitalized compared to
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